PDS Biotechnology Corp (PDSB)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$1.30

-0.11 (-7.80%)

Market Cap: $102.19M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

59%(22/37)

Avg Surprise

-23.68%

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.11

Range$-0.11 - $-0.11

1 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$-0.12+5.7%

60d ago$-0.12+5.7%

30d ago$-0.12+5.7%

7d ago$-0.110.0%

Current$-0.11

Revenue Consensus

Range$0 - $0

2 analysts

Period ending Dec 31, 2026

EPS Consensus$-0.11

Range$-0.11 - $-0.11

1 analysts

Revenue Consensus

Range$0 - $0

2 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.11	$-0.11 - $-0.11	-	-	1	-	-
Sep 30, 2026Sep 26EST	-	$-0.11	$-0.11 - $-0.11	-	-	1	1 0 30d	-
Jun 30, 2026Jun 26 Reported Aug 13, 2026Reported Aug 13	$-0.18	$-0.13	$-0.14 - $-0.12	-38.46%	Miss	3	No revisions (30d)	+14.3%
Mar 31, 2026Mar 26 Reported May 13, 2026Reported May 13	$-0.13	$-0.14	$-0.15 - $-0.13	+7.14%	Beat	2	No revisions (30d)	+38.1%
Dec 31, 2025Dec 25 Reported Mar 30, 2026Reported Mar 30	$-0.14	$-0.18	$-0.18 - $-0.18	+20.77%	Beat	1	1 0 30d	+33.3%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-0.19	$-0.20	$-0.21 - $-0.19	+5.00%	Beat	2	3 0 30d	+34.5%
Jun 30, 2025Jun 25 Reported Aug 13, 2025Reported Aug 13	$-0.21	$-0.23	$-0.25 - $-0.22	+8.70%	Beat	3	2 1 30d	+8.7%
Mar 31, 2025Mar 25 Reported May 14, 2025Reported May 14	$-0.21	$-0.25	$-0.31 - $-0.19	+16.00%	Beat	3	2 0 30d	+30.0%
Dec 31, 2024Dec 24 Reported Mar 27, 2025Reported Mar 27	$-0.21	$-0.28	$-0.29 - $-0.25	+23.64%	Beat	4	2 1 30d	+40.0%
Sep 30, 2024Sep 24 Reported Nov 14, 2024Reported Nov 14	$-0.29	$-0.28	$-0.33 - $-0.26	-3.57%	Miss	5	2 0 30d	+17.1%
Jun 30, 2024Jun 24 Reported Aug 13, 2024Reported Aug 13	$-0.23	$-0.33	$-0.40 - $-0.29	+30.30%	Beat	5	1 0 30d	+37.8%
Mar 31, 2024Mar 24 Reported May 15, 2024Reported May 15	$-0.30	$-0.37	$-0.45 - $-0.28	+18.92%	Beat	6	No revisions (30d)	+6.3%
Dec 31, 2023Dec 23 Reported Mar 27, 2024Reported Mar 27	$-0.35	$-0.42	$-0.60 - $-0.37	+16.67%	Beat	7	No revisions (30d)	+47.8%
Sep 30, 2023Sep 23 Reported Nov 14, 2023Reported Nov 14	$-0.35	$-0.47	$-0.50 - $-0.32	+25.53%	Beat	7	No revisions (30d)	-34.6%
Jun 30, 2023Jun 23 Reported Aug 14, 2023Reported Aug 14	$-0.37	$-0.34	$-0.39 - $-0.29	-8.82%	Miss	7	No revisions (30d)	-85.0%
Mar 31, 2023Mar 23 Reported May 15, 2023Reported May 15	$-0.32	$-0.30	$-0.36 - $-0.25	-6.67%	Miss	7	No revisions (30d)	+0.0%
Dec 31, 2022Dec 22 Reported Mar 28, 2023Reported Mar 28	$-0.67	$-0.29	$-0.33 - $-0.26	-131.03%	Miss	7	No revisions (30d)	-204.5%
Sep 30, 2022Sep 22 Reported Nov 14, 2022Reported Nov 14	$-0.26	$-0.28	$-0.32 - $-0.23	+7.14%	Beat	7	No revisions (30d)	-13.0%
Jun 30, 2022Jun 22 Reported Aug 8, 2022Reported Aug 8	$-0.20	$-0.28	$-0.34 - $-0.15	+28.57%	Beat	6	No revisions (30d)	+9.1%
Mar 31, 2022Mar 22 Reported May 11, 2022Reported May 11	$-0.32	$-0.22	$-0.26 - $-0.18	-45.45%	Miss	5	No revisions (30d)	-128.6%
Dec 31, 2021Dec 21 Reported Mar 31, 2022Reported Mar 31	$-0.22	$-0.24	$-0.28 - $-0.18	+8.33%	Beat	6	1 0 30d	-22.2%
Sep 30, 2021Sep 21 Reported Nov 10, 2021Reported Nov 10	$-0.23	$-0.20	$-0.27 - $-0.17	-15.00%	Miss	6	No revisions (30d)	+0.0%
Jun 30, 2021Jun 21 Reported Aug 12, 2021Reported Aug 12	$-0.22	$-0.16	$-0.24 - $-0.12	-37.50%	Miss	7	No revisions (30d)	-15.8%
Mar 31, 2021Mar 21 Reported May 13, 2021Reported May 13	$-0.14	$-0.17	$-0.23 - $-0.17	+17.65%	Beat	4	No revisions (30d)	+64.1%
Dec 31, 2020Dec 20 Reported Mar 18, 2021Reported Mar 18	$-0.18	$-0.19	$-0.20 - $-0.18	+5.26%	Beat	3	No revisions (30d)	+78.6%
Sep 30, 2020Sep 20 Reported Nov 11, 2020Reported Nov 11	$-0.23	$-0.14	$-0.27 - $-0.14	-64.29%	Miss	2	No revisions (30d)	+75.0%
Jun 30, 2020Jun 20 Reported Aug 13, 2020Reported Aug 13	$-0.19	$-0.23	$-0.26 - $-0.20	+17.39%	Beat	2	No revisions (30d)	+74.7%
Mar 31, 2020Mar 20 Reported May 13, 2020Reported May 13	$-0.39	$-0.15	$-0.15 - $-0.15	-160.00%	Miss	1	No revisions (30d)	-126.5%
Dec 31, 2019Dec 19 Reported Mar 27, 2020Reported Mar 27	$-0.84	$-0.92	$-1.00 - $-0.85	+8.70%	Beat	2	No revisions (30d)	-740.0%
Sep 30, 2019Sep 19 Reported Nov 7, 2019Reported Nov 7	$-0.92	$-0.82	-	-12.20%	Miss	-	-	+59.8%
Jun 30, 2019Jun 19 Reported Aug 1, 2019Reported Aug 1	$-0.75	N/A	-	N/A	Beat	-	-	+90.9%
Mar 31, 2019Mar 19 Reported May 14, 2019Reported May 14	$1.47	N/A	-	N/A	Beat	-	-	+111.0%
Dec 31, 2018Dec 18 Reported Feb 21, 2019Reported Feb 21	$-0.10	N/A	-	+96.15%	Beat	0	No revisions (30d)	+98.9%
Sep 30, 2018Sep 18 Reported Nov 1, 2018Reported Nov 1	$-2.29	$-0.27	$-0.27 - $-0.27	-748.15%	Miss	0	No revisions (30d)	+69.1%
Jun 30, 2018Jun 18 Reported Aug 1, 2018Reported Aug 1	$-8.20	$-10.52	-	+22.05%	Beat	-	-	+6.8%
Mar 31, 2018Mar 18 Reported May 1, 2018Reported May 1	$-13.40	$-10.52	-	-27.38%	Miss	-	-	-59.5%
Dec 31, 2017Dec 17 Reported Mar 1, 2018Reported Mar 1	$-9.00	$-8.62	-	-4.41%	Miss	-	-	-36.4%
Sep 30, 2017Sep 17 Reported Nov 1, 2017Reported Nov 1	$-7.40	$-9.55	-	+22.51%	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Aug 1, 2017Reported Aug 1	$-8.80	$-8.74	-	-0.69%	Miss	-	-	-
Mar 31, 2017Mar 17 Reported May 3, 2017Reported May 3	$-8.40	$-8.45	-	+0.59%	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Mar 2, 2017Reported Mar 2	$-6.60	$-8.31	-	+20.58%	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-2.03	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-544.00%	ROIC	-2922.99%
Financial Health
Debt/Equity	-1.21x	Interest Coverage	-4.18x
Current Ratio	0.57x	Quick Ratio	0.57x
Trading Statistics
Beta	1.17	Avg Volume	22.98M
52-Week High	$1.79	52-Week Low	$0.20

Technical Indicators Dashboard

Moving Averages

SMA 10$1.23

SMA 20$1.01

SMA 50$0.61

SMA 200$0.81

EMA 10$1.24

EMA 20$1.05

EMA 50$0.81

EMA 200$0.82

MACD

Line: 0.23Signal: 0.19Hist: 0.04

ADX

ADX: 61.8+DI: 40.9-DI: 15.1

Aroon & PSAR

Aroon Up92.0

Aroon Down8.0

PSAR$1.79

Bollinger Bands

Upper Band$1.59

Lower Band$0.43

%B Position11448%(Upper)

Band Width0.75

RSI (14-Day)

Neutral

62.4

Momentum Oscillators

Stoch %K67.6

Stoch %D80.3

Williams %R-45.0

ROC (10d)84.1%

Momentum0.59

CCI (20d)74.0

MFI (14d)70.2

Volatility Measures

ATR (14d)$0.20(15.1%)

StdDev (20d)0.29

Hist Vol269.8%(High)

Volume Flow

VWAP$1.26

OBV1.2B

AD Line-273.1M

CMF (20d)0.145

Volume Metrics

Avg Vol (20d)13.7M

Vol Ratio0.7x

VWMA (20d)$1.11

Pivot Points

R3$1.88

R2$1.78

R1$1.59

Pivot Point$1.49

S1$1.30

S2$1.20

S3$1.01

Advanced Oscillators

TSI36.94

Ultimate Osc59.0

KST2511.68

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$0	$0	$0	$0	$0	$0	$59,066	$0	$0	$0	$0	$0
Cost of Revenue	$0	$0	$15,131	$0	$0	$0	$15,127	$0	$0	$0	$14,405	$0
Gross Profit	$0	$0	$-15,131	$0	$0	$0	$-15,127	$0	$0	$0	$-14,405	$0

Operating Expenses	$6.50M	$6.52M	$6.67M	$8.14M	$7.62M	$9.11M	$7.36M	$10.18M	$8.68M	$10.10M	$10.41M	$10.52M
R&D	$3.27M	$3.46M	$4.41M	$4.58M	$4.21M	$5.83M	$4.53M	$6.80M	$4.53M	$6.70M	$7.47M	$6.45M
SG&A	$3.23M	$3.06M	$2.27M	$3.56M	$3.41M	$3.27M	$2.83M	$3.37M	$4.16M	$3.39M	$2.94M	$4.07M
Operating Income	$-6,496,734	$-6,521,087	$-6,674,708	$-8,140,142	$-7,623,351	$-9,105,758	$-7,360,570	$-10,178,694	$-8,684,304	$-10,097,627	$-10,406,961	$-10,519,686

Interest Income	$125,405	$186,814	$224,659	$281,109	$333,624	$377,849	$503,942	$666,770	$675,209	$668,895	$683,540	$739,404
Interest Expense	$3.38M	$1.01M	$1.11M	$1.15M	$2.14M	$930,878	$1.10M	$1.21M	$1.19M	$1.17M	$1.17M	$1.07M
Income Before Tax	$-9,750,575	$-7,349,056	$-7,562,919	$-9,009,411	$-9,434,208	$-9,658,787	$-7,952,352	$-10,726,658	$-9,197,066	$-10,603,477	$-10,898,214	$-10,849,169
Income Tax Expense	$0	$0	$0	$0	$0	$-1,169,820	$0	$0	$-869,169	$0	$0	$0

Net Income	$-9,750,575	$-7,349,056	$-7,562,919	$-9,009,411	$-9,434,208	$-8,488,967	$-7,952,352	$-10,726,658	$-8,327,897	$-10,603,477	$-10,898,216	$-10,849,169

EBITDA	$-6,216,056	$-6,057,121	$-6,185,169	$-8,412,852	$-6,494,194	$-8,818,051	$-7,047,673	$-9,858,438	$-8,375,732	$-9,822,656	$-10,102,173	$-10,377,183
EBIT	$-6,496,734	$-6,521,087	$-6,674,708	$-8,140,142	$-7,623,351	$-9,105,758	$-7,360,570	$-10,178,694	$-8,684,304	$-10,097,627	$-10,406,961	$-10,519,686

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about PDSB

News

Form S-3 PDS Biotechnology Corp For: 14 October By Investing.com

This article announces the filing of a Form S-3 by PDS Biotechnology Corp on October 14. The content appears to be a standard financial news brief from Investing.com...

Investing.com Nigeria•Oct 14, 2026 11:12 PM ET10/14/26•Neutral

With 105M shares outstanding, PDS Biotechnology (PDSB) sets out a stockholder resale offering.

PDS Biotechnology (PDSB) has registered for resale up to 110,001,540 shares of common stock by selling stockholders...

Stock Titan•Oct 14, 2026 4:40 PM ET10/14/26•Neutral

PDSB Jumps As JAMA Data And Nant Capital Deal Shift Outlook

PDS Biotechnology Corporation (PDSB) stock has surged 12.5% following positive Phase 2 immunotherapy trial results published in JAMA Oncology...

Timothy Sykes•Oct 13, 2026 12:44 PM ET10/13/26•Bullish

PDSB Jumps As JAMA Data And Nant Capital Deal Shift Outlook

PDS Biotechnology Corporation (PDSB) shares surged by 12.5% following promising Phase 2 immunotherapy trial data published in JAMA Oncology and a strategic deal with Nant Capital. The data showed their PDS0101 drug...

Timothy Sykes•Oct 13, 2026 12:11 PM ET10/13/26•Bullish

PDSB Jumps As JAMA Data And Nant Capital Deal Reshape The Story

PDS Biotechnology (PDSB) stock has surged by 13.08% due to positive Phase 2 clinical data published in JAMA Oncology for its HPV16-targeted immunotherapy, PDS0101...

StocksToTrade•Oct 13, 2026 12:11 PM ET10/13/26•Bullish

PDSB Valuation and Fair Value

P/E: -2.0x
P/B: -20.2x

See GNG's fair value

PDSB Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROIC: -2923.0%
ROE: -544.0%

PDSB Competitors

Company	Ticker
Armata Pharmaceuticals Inc	ARMP
Unicycive Therapeutics Inc	UNCY
Vivani Medical Inc.	VANI
Inovio Pharmaceuticals Inc	INO
Definitive Healthcare Corp	DH
Corbus Pharmaceuticals Holding	CRBP
Genelux Corporation Common Stock	GNLX
Humacyte Inc	HUMA

Sector: Healthcare

PDSB Analyst Ratings

Consensus: Buy
Analysts: 3
Strong Buy: 0
Buy: 3
Hold: 0
Sell: 0
Strong Sell: 0

PDSB Bull Case vs Bear Case

Bull case

PDSB beat EPS estimates in 75.0% of its last 8 reported quarters.

PDSB Earnings: Beat Rate and Next Report

Beat rate: 6 of 8 quarters (75.0%)
Average surprise: 4.9%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.11
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 1 up, 0 down

Frequently Asked Questions About PDSB

Does PDSB pay dividends?

PDS Biotechnology Corp (PDSB) does not currently pay a regular dividend.

What is PDSB's market cap?

PDS Biotechnology Corp (PDSB) has a market capitalization of $102.19M with a current stock price of $1.30.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In

Earnings

Performance (10Y)

Upcoming Estimates

Key Metrics

Technical Indicators Dashboard

Moving Averages

MACD

ADX

Aroon & PSAR

Bollinger Bands

RSI (14-Day)

Momentum Oscillators

Volatility Measures

Volume Flow

Volume Metrics

Pivot Points

Advanced Oscillators

Financial Data

Related GNG Research

News

Form S-3 PDS Biotechnology Corp For: 14 October By Investing.com

With 105M shares outstanding, PDS Biotechnology (PDSB) sets out a stockholder resale offering.

PDSB Jumps As JAMA Data And Nant Capital Deal Shift Outlook

PDSB Jumps As JAMA Data And Nant Capital Deal Shift Outlook

PDSB Jumps As JAMA Data And Nant Capital Deal Reshape The Story

PDSB Valuation and Fair Value

PDSB Profitability: Margins, ROIC and FCF

PDSB Competitors

PDSB Analyst Ratings

PDSB Bull Case vs Bear Case

Bull case

PDSB Earnings: Beat Rate and Next Report

Frequently Asked Questions About PDSB

Related stocks

Get full access to GNG Research